DILIC
WST icon

Dai-ichi Life Insurance Company’s West Pharmaceutical WST Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.84M Buy
+21,847
New +$6.68M 0.18% 113
2026
Q1 		– Sell
-29,599
Closed -$8.14M – 499
2025
Q4 		$8.14M Buy
29,599
+3,527
+14% +$965K 0.21% 96
2025
Q3 		$6.84M Buy
+26,072
New +$6.34M 0.17% 134
2024
Q4 		– Sell
-4,480
Closed -$1.34M – 514
2024
Q3 		$1.34M Hold
4,480
– – 0.03% 350
2024
Q2 		$1.48M Hold
4,480
– – 0.04% 320
2024
Q1 		$1.77M Hold
4,480
– – 0.04% 314
2023
Q4 		$1.58M Sell
4,480
-100
-2% -$35.4K 0.03% 319
2023
Q3 		$1.72M Buy
4,580
+4,000
+690% +$1.55M 0.04% 301
2023
Q2 		$222K Hold
580
– – ﹤0.01% 462
2023
Q1 		$201K Buy
+580
New +$169K ﹤0.01% 471
2022
Q2 		– Sell
-11,365
Closed -$4.67M – 523
2022
Q1 		$4.67M Hold
11,365
– – 0.07% 212
2021
Q4 		$5.33M Buy
11,365
+1,921
+20% +$827K 0.07% 212
2021
Q3 		$4.01M Hold
9,444
– – 0.05% 245
2021
Q2 		$3.39M Buy
9,444
+8,580
+993% +$2.83M 0.04% 279
2021
Q1 		$243K Hold
864
– – ﹤0.01% 525
2020
Q4 		$245K Hold
864
– – ﹤0.01% 495
2020
Q3 		$238K Sell
864
-48
-5% -$12.7K ﹤0.01% 479
2020
Q2 		$207K Buy
+912
New +$179K ﹤0.01% 483

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dai-ichi Life Insurance Company's WST Position: Q2 2026 in Review

Dai-ichi Life Insurance Company opened a new position in West Pharmaceutical (WST) in Q2 2026: 21,847 shares worth $7.84M. The stake represents 0.18% of the portfolio and ranks #113 among its holdings. This is a return to the name: Dai-ichi Life Insurance Company previously reported a position in WST as recently as Q4 2025.

Dai-ichi Life Insurance Company first reported a position in WST in Q2 2020 and has held it in 18 quarters since. The position peaked at $8.14M in Q4 2025. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Dai-ichi Life Insurance Company held 21,847 shares of West Pharmaceutical worth $7.84M as of Q2 2026.
  • West Pharmaceutical was a new Dai-ichi Life Insurance Company position in Q2 2026.
  • West Pharmaceutical made up 0.18% of Dai-ichi Life Insurance Company's portfolio in Q2 2026, its #113 holding.
  • Dai-ichi Life Insurance Company first reported a position in West Pharmaceutical in Q2 2020 and has held it in 18 quarters since.
  • Dai-ichi Life Insurance Company's West Pharmaceutical position peaked at $8.14M in Q4 2025.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Dai-ichi Life Insurance Company's 13F filing for Q2 2026, filed 12 Aug 2026.